Study 11 of 27 for search of: "Ileus"
Previous Study Return to Search Results Next Study

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Acupuncture to Prevent Postoperative Bowel Paralysis (Paralytic Ileus)
This study has been suspended.
Sponsored by: National Center for Complementary and Alternative Medicine (NCCAM)
Information provided by: National Center for Complementary and Alternative Medicine (NCCAM)
ClinicalTrials.gov Identifier: NCT00065234
  Purpose

The purpose of this study is to determine if acupuncture is effective in preventing prolonged postoperative paralysis of the gastrointestinal tract among patients undergoing colostomy/ileostomy closure.


Condition Intervention Phase
Ileus
Neoplasms
Procedure: Acupuncture
Phase II

MedlinePlus related topics: Acupuncture Cancer Paralysis
U.S. FDA Resources
Study Type: Interventional
Study Design: Prevention, Randomized, Single Blind, Active Control, Parallel Assignment, Efficacy Study
Official Title: Acupuncture to Prevent Postoperative Paralytic Ileus

Further study details as provided by National Center for Complementary and Alternative Medicine (NCCAM):

Estimated Enrollment: 100
Study Start Date: September 2003
Estimated Study Completion Date: May 2006
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Previous surgical cancer treatment with ileostomy/colostomy, now scheduled for closure
  • Hospital admission must be same day as surgery

Exclusion Criteria:

  • Incapacitating disease
  • Concurrent herbal or laxative use
  • Use of Heparin or Coumadin
  • Upper or lower extremity deformities
  • Chronic constipation prior to cancer diagnosis
  • History of cerebrovascular accident or spinal cord injury
  • Chronic pain that has been treated with any form of major opioid or weak opioids (=/> 30mg/24 hours)
  • Pacemaker or metal implants
  • Concurrent alternative medicine/herbal use
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00065234

Locations
United States, Texas
MD Anderson Cancer Center
Houston, Texas, United States, 77030
Sponsors and Collaborators
Investigators
Principal Investigator: Joseph S Chiang, MD M.D. Anderson Cancer Center
  More Information

Study ID Numbers: R21 AT001065-01A1, ChiangJ
Study First Received: July 18, 2003
Last Updated: August 16, 2006
ClinicalTrials.gov Identifier: NCT00065234  
Health Authority: United States: Federal Government

Keywords provided by National Center for Complementary and Alternative Medicine (NCCAM):
Colostomy
Ileostomy

Study placed in the following topic categories:
Intestinal Obstruction
Paralysis
Intestinal pseudo-obstruction
Ileus
Mitochondrial neurogastrointestinal encephalopathy syndrome
Digestive System Diseases
Hollow visceral myopathy
Gastrointestinal Diseases
Intestinal Diseases
Intestinal Pseudo-Obstruction

Additional relevant MeSH terms:
Neoplasms

ClinicalTrials.gov processed this record on January 16, 2009